Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.

David Allsup; Z Craig; D Cairns; D Howard; A Hockaday; A Bloor; Z Soe; Chris Pepper; valter gattei; Antonella Zucchetto; P Robbe; R Clifford; A Schuh; T Munir; A Rawstron; P Hillmen

doi:10.1002/ajh.26483

Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.

David Allsup
, Z Craig
, D Cairns
, D Howard
, A Hockaday
, A Bloor
, Z Soe
, Chris Pepper
, valter gattei
, Antonella Zucchetto
, P Robbe
, R Clifford
, A Schuh
, T Munir
, A Rawstron
, P Hillmen

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	E168-E171
Journal	American Journal of Hematology
Volume	97
Issue number	5
DOIs	https://doi.org/10.1002/ajh.26483
Publication status	Published - May 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/ajh.26483

Cite this

Allsup, D., Craig, Z., Cairns, D., Howard, D., Hockaday, A., Bloor, A., Soe, Z., Pepper, C., gattei, V., Zucchetto, A., Robbe, P., Clifford, R., Schuh, A., Munir, T., Rawstron, A., & Hillmen, P. (2022). Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. American Journal of Hematology, 97(5), E168-E171. https://doi.org/10.1002/ajh.26483

@article{9f8d76d4059c4765b3abf3e04dfa818b,

title = "Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.",

author = "David Allsup and Z Craig and D Cairns and D Howard and A Hockaday and A Bloor and Z Soe and Chris Pepper and valter gattei and Antonella Zucchetto and P Robbe and R Clifford and A Schuh and T Munir and A Rawstron and P Hillmen",

year = "2022",

month = may,

doi = "10.1002/ajh.26483",

language = "Undefined/Unknown",

volume = "97",

pages = "E168--E171",

journal = "American Journal of Hematology",

issn = "0361-8609",

number = "5",

}

Allsup, D, Craig, Z, Cairns, D, Howard, D, Hockaday, A, Bloor, A, Soe, Z, Pepper, C, gattei, V, Zucchetto, A, Robbe, P, Clifford, R, Schuh, A, Munir, T, Rawstron, A & Hillmen, P 2022, 'Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.', American Journal of Hematology, vol. 97, no. 5, pp. E168-E171. https://doi.org/10.1002/ajh.26483

Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. / Allsup, David; Craig, Z; Cairns, D et al.
In: American Journal of Hematology, Vol. 97, No. 5, 05.2022, p. E168-E171.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.

AU - Allsup, David

AU - Craig, Z

AU - Cairns, D

AU - Howard, D

AU - Hockaday, A

AU - Bloor, A

AU - Soe, Z

AU - Pepper, Chris

AU - gattei, valter

AU - Zucchetto, Antonella

AU - Robbe, P

AU - Clifford, R

AU - Schuh, A

AU - Munir, T

AU - Rawstron, A

AU - Hillmen, P

PY - 2022/5

Y1 - 2022/5

UR - https://doi.org/10.1002/ajh.26483

U2 - 10.1002/ajh.26483

DO - 10.1002/ajh.26483

M3 - Article

C2 - 35108412

SN - 0361-8609

VL - 97

SP - E168-E171

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 5

ER -

Allsup D, Craig Z, Cairns D, Howard D, Hockaday A, Bloor A et al. Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. American Journal of Hematology. 2022 May;97(5):E168-E171. doi: 10.1002/ajh.26483

Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.

UN SDGs

Access to Document

Other files and links

Cite this